Risankizumab for Ulcerative Colitis
To the Editor The INSPIRE and COMMAND studies provided important insights into the efficacy and safety of risankizumab for treatment of moderately to severely active ulcerative colitis.
To the Editor The INSPIRE and COMMAND studies provided important insights into the efficacy and safety of risankizumab for treatment of moderately to severely active ulcerative colitis.
